| Novartis Pharma Schweiz AG - Exforge HCT 5 mg/160 mg/12.5 mg, Filmtabletten | | 59407 | | 01 | | Exforge HCT 5 mg/160 mg/12.5 mg | | Filmtabletten | | C09DX01 | | Valsartan, Amlodipine and Hydrochlorothiazide | | 16.09.2009 | | |
| | Composition | | amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Amlodipine | 5 mg | | Hydrochlorothiazide | 12.5 mg | | Valsartan | 160 mg |
| | BAG: Active Agent | Dose |
|---|
| Amlodipine | 5 mg | | Hydrochlorothiazide | 12.5 mg | | Valsartan | 160 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
